The straight answer
This is the rare case where the honest answer is yes. Type 2 diabetes is one of the very few conditions with peptides that are truly proven to help, and several of them are in this library. The catch: they are real prescription medicines with real risks, not research chemicals to buy online and dose yourself. What works is the FDA-approved GLP-1 family (like semaglutide, tirzepatide, liraglutide, dulaglutide, and exenatide), prescribed and monitored by a doctor as part of a full treatment plan.
What actually treats it
Treatment starts with the basics that move the needle most: food changes, movement, weight loss, and often metformin, plus checking blood pressure and cholesterol. From there, doctors add proven medicines matched to you, commonly a GLP-1 peptide (semaglutide, tirzepatide, and others) or an SGLT-2 inhibitor pill, both of which lower blood sugar and also protect the heart and kidneys; insulin is added when needed.
From our library
Compounds here with any tie to type 2 diabetes — rated honestly for this specific use.
- Proven
Semaglutide
Worth a lookOne of the best-proven diabetes drugs there is. Sold as Ozempic (weekly shot) and Rybelsus (daily pill), it lowers blood sugar better than older drugs while causing weight loss instead of weight gain, and it cuts heart attack and stroke risk. Backed by huge multi-year trials. Prescription only, with real GI side effects, so it needs a doctor.
- Proven
Tirzepatide
Worth a lookFDA-approved for Type 2 diabetes as Mounjaro. It hits two gut-hormone signals at once and produced the single largest blood-sugar (A1C) drop of any approved diabetes drug in head-to-head trials, plus major weight loss. Prescription only, injection, needs medical supervision.
- Proven
Liraglutide
Worth a lookFDA-approved for Type 2 diabetes as Victoza (a daily shot). One of only two GLP-1s with proven reduction in cardiovascular deaths. Older than semaglutide and dosed daily, but a solid, well-studied option a doctor can prescribe.
- Proven
Dulaglutide
Worth a lookFDA-approved for Type 2 diabetes as Trulicity, a once-a-week shot. Lowers blood sugar, gives modest weight loss, and lowers the risk of heart attack and stroke. Prescription only.
- Proven
Exenatide
Worth a lookOne of the first GLP-1 medicines FDA-approved for Type 2 diabetes. Helps the body release insulin at the right time, lowers blood sugar, and often causes modest weight loss. Largely replaced by newer weekly options, but proven and prescribable.
- Moderate
Mazdutide
Worth a lookA weekly injection that turns on two gut-hormone signals (GLP-1 and glucagon). Large human trials show big improvements in blood sugar and weight in Type 2 diabetes. Approved as a real medicine, but so far only in China, not the US.
- Emerging
Orforglipron
Worth a lookA once-daily GLP-1 pill (no needle) that has strong late-stage human trial data in Type 2 diabetes for lowering blood sugar and weight. Promising and close to market, but not yet FDA-approved, so it's not something you can be prescribed for diabetes yet.
- Emerging
Retatrutide
Worth a lookAn experimental weekly shot that activates three gut-hormone signals at once. Human trials show large drops in blood sugar and weight, but it is still in testing and not approved by any regulator. One to watch, not to use on your own.
- Emerging
Survodutide
Worth a lookAn experimental weekly injection (GLP-1 plus glucagon) with human trial data showing better blood sugar control, weight loss, and less liver fat. Still investigational and not approved anywhere.
- Emerging
Cagrilintide
Worth a lookA weekly injection copying the 'I'm full' hormone amylin. In trials, especially paired with semaglutide (CagriSema), it improves blood sugar and drives major weight loss. Still investigational, not yet an approved diabetes treatment.
- Early
ARA-290
SpeculativeNot a blood-sugar drug at heart, but one small 8-week trial in people with Type 2 diabetes and painful nerve damage improved both nerve pain and A1C. It's really being studied for diabetic nerve pain, a common complication. Human evidence is tiny, short, and it's not an approved medicine. Interesting, not proven.
- Early
MOTS-c
SpeculativeA natural mitochondrial peptide studied as 'exercise in a shot' for metabolism and blood sugar. The metabolic results are real but come only from animals and lab dishes, with no completed human trials. No proof it helps people with diabetes.
- Early
5-Amino-1MQ
Not reallyBlocks a metabolism enzyme (NNMT) and improved blood sugar in mice, but it has never been tested in a single human. Sold as a research chemical. No basis to use it for diabetes.
Also being studied (not in our library)
- Insulin — The original peptide medicine for diabetes. It's a peptide hormone, and injected insulin is a proven, sometimes life-saving treatment doctors add when the body can no longer keep blood sugar in range on other medicines.
- Pramlintide (Symlin) — An FDA-approved amylin-analog peptide used alongside mealtime insulin to smooth out blood sugar spikes. Proven, but a niche add-on rather than a first choice.
- Efpeglenatide — An investigational once-weekly GLP-1 peptide with large trial data showing better blood sugar and lower heart and kidney risk. Not yet widely approved, but part of the same proven drug family.
Bottom line
Unlike most conditions, Type 2 diabetes really does have proven peptide treatments, chiefly the GLP-1 family, and they are among the best diabetes medicines available. They only help, though, when prescribed and monitored by a doctor, not bought and self-dosed.